Transaction #7002 · Form 4 · 0001193125-25-276244
HERON THERAPEUTICS, INC. /DE/ · Stock award · Stock Option (Right to Buy)
HERON THERAPEUTICS, INC. /DE/ · Transacted November 8, 2025 · Filed November 12, 2025
What does this filing report?
An SEC Form 4 filing for HERON THERAPEUTICS, INC. /DE/ records a stock award involving Stock Option (Right to Buy) on November 8, 2025. The reported quantity was 227,272. The filing date is November 12, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company CIK
- 0000818033
- Security type
- Derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 227,272
- Reported price
- 1.1
- Reference value
- 249,999.2
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 227,272
- Ownership description
- Not reported
- SEC acceptance time
- Nov 12, 2025, 9:20 AM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Cusack Thomas ↗
Director
CIK 0002094824
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Common Stock
- Underlying quantity
- 227,272
- Conversion / exercise price
- 1.1
- Exercise date
- Not reported
- Expiration date
- November 8, 2035
Filing footnotes & remarks
- F1
- The shares were granted as restricted stock units which vest in 16 equal quarterly installments beginning one quarter after the date of grant.
- F2
- Each restricted stock unit represents a contingent right to receive one share of common stock.
- F3
- The stock options vest and become exercisable in 48 equal monthly installments beginning one month after the date of grant.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.